Analysts who follow Beam Therapeutics Inc (BEAM) on average expect it to increase 79.91% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns BEAM an Analyst Ranking of 44, which means it ranks higher than 44 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating BEAM a Strong Buy today. Find out what this means to you and get the rest of the rankings on BEAM!